Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS: A Multicentral Randomized Pilot Trial

NCT05259631 is registered in ClinicalTrials.gov with Negovsky Reanimatology Research Institute as lead sponsor.

NCT NCT05259631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05259631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS: A Multicentral Randomized Pilot Trial
Lead sponsor
Negovsky Reanimatology Research Institute
Phase
Phase 3
Overall status
Suspended
Start date
March 14, 2022
Completion date
February 25, 2026
Enrollment
310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome